Table 3.
| Report (Author/year) | Isolates | Sample used | Susceptibility method used | Alternative sensitive antibiotics | Resistance in addition to vancomycin |
|---|---|---|---|---|---|
| Sharma et al, 2010 | Enterococcus species | Vitreous culture | Vitek-2 | Ch, linezolid, Q/D | Ampicillin, LFC, erythromycin, penicillin, streptomycin, tetracycline, CFC |
| Das et al, 2011 | CNS | Vitreous culture | Disk diffusion | – | GFC, OFC, CFC, MFC (I), piperacillin-tazobactam (I) |
| Hernandez-Da Mota et al, 2011 | CNS | Vitreous culture | In vitro tests not performed. Clinically responsive to Q/D | NA | – |
| Stroh et al, 2012 | Staphylococcus aureus | Aqueous & Vitreous culture | Vitek-2 | Ch, linezolid, Q/D | MFC, clindamycin, imipenem, methicillin, |
| Bains et al, 2007 | Enterococcus faecium | Aqueous, Vitreous & donor corneal rim culture | MIC—broth microdilution (MIC 64 mg/mL) | NA | – |
| Tang et al, 2007 | Enterococcus faecalis | Vitreous culture | Information not available | Ampicillin, penicillin | All common antibiotics (not mentioned in paper) |
| Hillier et al, 2013 | Enterococcus gallinarum | Vitreous culture | Information not available | Ampicillin, clindamycin | – |
| Esmaeli et al, 2003 | Enterococcus species | Vitreous culture | Information not available | NA | – |
| Khera et al, 2013 | Bacillus, Staphylococcus, Enterococcus species | Vitreous culture | Disk diffusion | CFC, G, amikacin CFC, GFC – | Cefazolin, chloramphenicol Ofloxacin, A, Ch, G Cefazolin, CFC, OFC, A, G Ch, ceftazidime |
| Hernandez-Camarena et al, 2012 | Enterococcus faecium | Vitreous culture | MIC—broth microdilution (MIC 32 mg/mL) | Linezolid, tetracycline | – |
| Won et al, 2013 | Staphylococcus hominis | Vitreous culture | MIC—broth microdilution (MIC 8–16 mg/mL) | TMP/SMZ, teicoplanin | LFC, MFC, CFC, cefazolin |
| Relhan et al, 2014 | CNS | Vitreous culture | Disk diffusion | G, piperacillin-tazobactam | Ampicillin, erythromycin |
(I), intermediate sensitivity; A, amikacin; CFC, ciprofloxacin; Ch, chloramphenicol; CNS, coagulase-negative staphylococci; GFC, gatifloxacin; G, gentamicin; LFC, levofloxacin; MFC, moxifloxacin; MIC, minimum inhibitory concentration; NA, data not available; OFC, ofloxacin; Q/D, quinupristine-dalfopristine; TMP/SMZ, trimethoprim-sulfamethoxazole.